Quiero saber acerca de...

48230

Federal Register / Vol. 86, No. 164 / Friday, August 27, 2021 / Notices
individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation Cooperative Agreement U01
Clinical Trial Required; Investigator Initiated Extended Clinical Trial R01 Clinical Trial Required.
Date: September 27, 2021.
Time: 11:45 a.m. to 3:45 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G56, Rockville, MD 20892 Virtual Meeting.
Contact Person: Poonam Tewary, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G56, Rockville, MD
20852, 301 7617219, tewaryp@
mail.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS
Dated: August 23, 2021.
Tyeshia Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202118501 Filed 82621; 8:45 am BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

Dated: August 23, 2021.
David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy.

National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1

National Center for Advancing Translational Sciences; Notice of Closed Meetings
FR Doc. 202118505 Filed 82621; 8:45 am
Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the cooperative agreement applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; RFATR21009: Screening for Conditions by Electronic Nose Technology SCENT.

VerDate Sep<11>2014

17:52 Aug 26, 2021

Jkt 253001

Date: September 28, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate cooperative agreement applications.
Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1078, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Rahat Rani Khan, Ph.D., Scientific Review Officer, Office of Grants Management and Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701
Democracy Boulevard, Room 1078, Bethesda, MD 20892, 3018947319, khanr2@
csr.nih.gov.
Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; National Center for Advancing Translational Sciences Special Emphasis Panel.
Date: September 30, 2021
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate cooperative agreement applications.
Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1078, Bethesda, MD 20892 Virtual Meeting.
Contact Person: Alumit Ishai, Ph.D., Scientific Review Officer, Office of Grants Management and Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701
Democracy Boulevard, Suite 1000, Bethesda, MD 20892, 3018275819, alumit.ishai@
nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, BCooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS

BILLING CODE 414001P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings Pursuant to section 10d of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the provisions set forth in sections 552bc4 and 552bc6, Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material,
PO 00000

Frm 00117

Fmt 4703

Sfmt 9990

and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Neurological Sciences Training Initial Review Group; NST1 Study Section.
Date: September 2021, 2021.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, Virtual Meeting.
Contact Person: William C. Benzing, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, NINDS, NIH, NSC, 6001 Executive Blvd., Suite 3204, MSC 9529, Bethesda, MD 20892
9529, 301 4960660, benzingw@
mail.nih.gov.
Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; NIH BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity K99/R00.
Date: September 23, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, Virtual Meeting.
Contact Person: Lataisia Cherie Jones, Ph.D., Scientific Review Officer, NINDS, Scientific Review Branch, 6001 Executive Blvd., Suite 3208, Rockville, MD 20852, 301
4969223, lataisia.jones@nih.gov.
Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; HEAL Initiative: Pain Therapeutics Development Small Molecules and Biologics.
Date: September 27, 2021.
Time: 10:00 a.m. to 3:00 p.m..
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, Virtual Meeting.
Contact Person: Shanta Rajaram, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, NINDS/NIH, NSC, 6001 Executive Blvd., Suite 3208, MSC 9529, Bethesda, MD 20892, 301 4356033, rajarams@mail.nih.gov.
Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS
Dated: August 23, 2021.
Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy.
FR Doc. 202118508 Filed 82621; 8:45 am BILLING CODE 414001P

E:FRFM27AUN1.SGM

27AUN1